Torrent Pharmaceuticals
TORNTPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: Samir Mehta Listing date: Oct. 24, 1994 · Employees: 13505 · Ahmedabad · http://www.torrentpharma.com

Stock Price vs Company Growth
1d
0.1%
1w
6.1%
1m
4.9%
3m
9.6%
6m
41.1%
1y
67.1%
5y
26.9%
10y
27.2%
all
27.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,690 0.1%
2,410
2,746
Company Overview

Sales
10,474 Cr
Growth: 12.6%
Profit after Tax
1,406 Cr
Growth: 4.7%
Large Cap
91,057 Cr
P/E: 60.9x
Industry P/E: 35.5x
Fundamentals

Sales (Cr) ₹ 10,474
Growth 12.6%
EBITDA 30.7%
P/S 8.7x
Dividend 1.3%
P/E 60.9x
Book Value ₹ 216
PEG Ratio 4.8x
ROE 20.8%
P/B 12.4x
Shareholding Pattern

Institutions
Mirae Asset Focused Fund
2.16 %
Qualified Institutional Buyer
1.63 %
Uti-Unit Linked Insurance Plan
1.28 %
Promoters
Torrent Investments Private Limited
71.25 %
Others
Ifpf
0.1 %
Increase    Decrease    No change
Company Profile Detailed

Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).
Investors (87)
Followers (11)